- Home
- GNLX vs MIST Comparison
GNLX vs MIST Comparison
Compare GNLX & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | MIST |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | 95.3M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GNLX | MIST |
|---|---|---|
| Price | $2.11 | $0.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $18.83 | $5.57 |
| AVG Volume (30 Days) | 416.1K | ★ 930.5K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | $125.44 |
| Revenue Next Year | N/A | $462.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.86 | $0.63 |
| 52 Week High | $8.54 | $3.06 |
Technical Indicators
Market Signals| Indicator | GNLX | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 49.94 |
| Support Level | N/A | $0.75 |
| Resistance Level | $2.78 | $1.42 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 31.91 | 72.67 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.